(Q51563942)

7 April 2018

title

Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. (English)

1 reference

7 April 2018

1 reference

6

1 reference

7 April 2018

Henning Bundgaard

11

1 reference

7 April 2018

Anne Nørremølle

Anne Nørremølle

8

0 references

Lars Køber

10

Lars Køber

1 reference

7 April 2018

9

Ulla Feldt-Rasmussen

1 reference

7 April 2018

Lis Frydenreich Hasholt

7

Lis Hasholt

1 reference

7 April 2018

Morten S Jensen

4

Morten Jensen

1 reference

7 April 2018

Ole Havndrup

1

Ole Havndrup

1 reference

7 April 2018

Michael Christiansen

2

Michael Christiansen

1 reference

7 April 2018

author name string

Birgitte Stoevring

3

1 reference

7 April 2018

Jakob Hoffman-Bang

5

1 reference

7 April 2018

publication date

1 June 2010

1 reference

7 April 2018

European Journal of Heart Failure

published in

1 reference

7 April 2018

volume

12

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

page(s)

535-540

1 reference

7 April 2018

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

The heart in Anderson-Fabry disease and other lysosomal storage disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Cardiac manifestations of Anderson-Fabry disease in heterozygous females

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

The natural history of left ventricular systolic function in Anderson-Fabry disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Tissue Doppler imaging in Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Cardiac challenges in patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Two novel mutations (L32P) and (G85N) among five different missense mutations in six Danish families with Fabry's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Prevalence of uncontrolled hypertension in patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ073

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ073

1 reference

7 April 2018

PubMed ID

20498269

1 reference

7 April 2018